Cargando…
Cancer risk in HIV patients with incomplete viral suppression after initiation of antiretroviral therapy
BACKGROUND: Cancer causes significant morbidity and mortality among HIV patients in the US due to extended life expectancy with access to effective antiretroviral therapy. Low, detectable HIV RNA has been studied as a risk factor for adverse health outcomes, but its clinical impact on cancer risk re...
Autores principales: | Lee, Jennifer S., Cole, Stephen R., Achenbach, Chad J., Dittmer, Dirk P., Richardson, David B., Miller, William C., Mathews, Christopher, Althoff, Keri N., Moore, Richard D., Eron, Joseph J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988275/ https://www.ncbi.nlm.nih.gov/pubmed/29870537 http://dx.doi.org/10.1371/journal.pone.0197665 |
Ejemplares similares
-
Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients
por: Fatukasi, Terra V., et al.
Publicado: (2017) -
Loss to Clinic and Five-Year Mortality among HIV-Infected Antiretroviral Therapy Initiators
por: Edwards, Jessie K., et al.
Publicado: (2014) -
Rapid HIV Viral Load Suppression in those Initiating Antiretroviral Therapy at First Visit after HIV Diagnosis
por: Hoenigl, Martin, et al.
Publicado: (2016) -
Achieving consistency in measures of HIV‐1 viral suppression across countries: derivation of an adjustment based on international antiretroviral treatment cohort data
por: Johnson, Leigh F., et al.
Publicado: (2021) -
HIV and urethritis: time required for antiretroviral therapy to suppress HIV in semen
por: Matoga, Mitch, et al.
Publicado: (2023)